Naveen Mummudi
Overview
Explore the profile of Naveen Mummudi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manjali J, Keluskar G, Patel R, Bano N, Shaikh F, Malhotra R, et al.
J Cancer Res Ther
. 2024 Oct;
20(5):1464-1471.
PMID: 39412910
Background: This study reports the psychometric properties of OUTPASAT-35RT questionnaire from a large Indian cancer cohort treated with ambulatory radiotherapy (RT) at a tertiary-care comprehensive cancer center. Materials And Methods:...
2.
Mahajan A, B G, Wadhwa S, Agarwal U, Baid U, Talbar S, et al.
Explor Target Antitumor Ther
. 2024 Sep;
5(4):800.
PMID: 39280247
[This corrects the article DOI: 10.37349/etat.2023.00158.].
3.
Mahajan A, B G, Wadhwa S, Agarwal U, Baid U, Talbar S, et al.
Explor Target Antitumor Ther
. 2023 Sep;
4(4):657-668.
PMID: 37745691
Aim: The aim of this study was to investigate the feasibility of developing a deep learning (DL) algorithm for classifying brain metastases from non-small cell lung cancer (NSCLC) into epidermal...
4.
Nayak P, Sinha S, Goda J, Sahu A, Joshi K, Choudhary O, et al.
J Cancer Res Ther
. 2023 Jun;
19(2):366-375.
PMID: 37313912
Objectives: This study examines the role of tumor texture on computed tomography (CT) images as a complement to clinical prognostic factors in predicting survival in patients of non-small cell lung...
5.
Singh A, Sharin F, Ramalingam N, Tuljapurkar V, Mummudi N, Prabhash K, et al.
Indian J Cancer
. 2023 Mar;
60(3):359-365.
PMID: 36861710
Background: The ongoing coronavirus disease 2019 (COVID-19) pandemic has hard-pressed the health care systems beyond their capabilities, causing a lack of appropriate cancer treatment delivery. The aim of this study...
6.
Ghosh-Laskar S, Mummudi N, Kumar S, Chandre M, Mishra S, Tibdewal A, et al.
J Cancer Res Ther
. 2022 Dec;
18(Supplement):S285-S292.
PMID: 36510978
Objective: We report the long term follow-up, toxicity, and outcomes of patients with localized squamous cell carcinoma of the esophagus(ESCC) who underwent definitive chemo-radiotherapy(dCRT) at our institute. Materials And Methods:...
7.
Krishnamurthy R, Mummudi N, Goda J, Chopra S, Heijmen B, Swamidas J
JCO Glob Oncol
. 2022 Nov;
8:e2100393.
PMID: 36395438
The radiotherapy (RT) process from planning to treatment delivery is a multistep, complex operation involving numerous levels of human-machine interaction and requiring high precision. These steps are labor-intensive and time-consuming...
8.
Nilsson M, Olafsdottir H, Alexandersson von Dobeln G, Villegas F, Gagliardi G, Hellstrom M, et al.
Front Oncol
. 2022 Aug;
12:917961.
PMID: 35912196
Background: The globally dominant treatment with curative intent for locally advanced esophageal squamous cell carcinoma (ESCC) is neoadjuvant chemoradiotherapy (nCRT) with subsequent esophagectomy. This multimodal treatment leads to around 60%...
9.
Sengar M, Chinnaswamy G, Ranganathan P, Ashok A, Bhosale S, Biswas S, et al.
Nat Cancer
. 2022 Apr;
3(5):547-551.
PMID: 35379984
Patients with cancer are at higher risk for adverse coronavirus disease 2019 (COVID-19) outcomes. Here, we studied 1,253 patients with cancer, who were diagnosed with severe acute respiratory syndrome coronavirus...
10.
Joshi P, Joshi K, Nair S, Bhati M, Nair D, Bal M, et al.
South Asian J Cancer
. 2021 Dec;
10(3):167-171.
PMID: 34938679
Tumors of parapharyngeal space (PPS) are rare and histologically diverse. The management of these tumors requires diligent assessment and planning with due consideration of various anatomical and pathological aspects of...